Found 25 results
Author Title [ Type(Desc)] Year
Filters: Author is Carter, SL  [Clear All Filters]
Conference Paper
D. Wall, Carter, S. L., Kapoor, N., Kamani, N., Kernan, N., Jensen, L., Brochstein, J., Frangoul, H., Goyal, R., Horan, J., Pietryga, D., Wagner, J., and Kurtzberg, J., Busulfan/Melphalan/ATG (Bu/Mel/ATG) as a Preparative Regimen for Unrelated Donor Cord Blood Transplantation (UCBT): The COBLT Experience, in 2003 Tandem BMT Meeting of the American Society for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry, Keystone, CO, 2003.
J. Kurzberg, Wagner, E. L., Cairo, M. S., Carter, S. L., Kernan, N. A., Jensen, L., Gindy, L., Issitt, L., and Fraser, J. K., The Cord Blood Transplantation (COBLT) Study: The First Two Years of Recruitment and Collection by the COBLT Cord Blood Banks, in American Society for Blood and Marrow Transplantation Annual Meeting, Anaheim, CA, 2000.
J. E. Wagner, Eapen, M., Carter, S. L., Haut, P., Peres, E., Schultz, K. R., Thompson, J., Wall, D., and Kurtzberg, J., Lack of Enhanced Survival after Double Umbilical Cord Blood (UCB) Transplant Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the BMT-CTN Randomized Trial, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
J. Kurtzberg, Wagner, E., Fraser, J., Cairo, M., Jensen, L., Cohen, G., Carter, S. L., and Kernan, N., Results of the Cord Blood Transplantation Study (COBLT) Unrelated Donor Banking Program from Donor Screening to Characterization of Banked Units, in 45th American Society of Hematology Annual Meeting, San Diego, CA, 2003.
J. Kurtzberg, Carter, S. L., Wagner, J. E., Baxter-Lowe, L. A., Wall, D., Kapoor, N., Guinan, E., Feig, S., Wagner, E., and Kernan, N. A., Umbilical Cord Blood Transplantation in Pediatric Patients with Malignant Diseases: Results of a Prospective, Multi-Institutional NHLBI Sponsored Trial, in 2005 ASBMT Tandem BMT Meetings, Keystone, CO, 2005.
Journal Article
C. G. Brunstein, Fuchs, E. J., Carter, S. L., Karanes, C., Costa, L. J., Wu, J., Devine, S. M., ,, Aljitawi, O. S., Cutler, C. S., Jagasia, M. H., Ballen, K. K., Eapen, M., O’Donnell, P. V., and , Alternative Donor Transplantation: Results of Parallel Phase II Trials Using HLA-Mismatched Related Bone Marrow or Unrelated Umbilical Cord Blood Grafts, Blood, vol. 118, no. 2, pp. 282-288, 2011.
J. Kurtzberg, Wagner, E. L., Cairo, M. S., Reese, M., Chun, S., Carter, S. L., Kernan, N. A., Jensen, L., and Fraser, J. K., Assay method, cord blood bank, nucleated cell count, and neonatal factors influence the CD34+ cell count in cord blood: The COBLT Experience, 2000.
J. Kurtzberg, Wagner, E. L., Gindy, L., Issitt, I., Carter, S. L., Kernan, N. A., Jensen, L., Cairo, M. S., and Fraser, J. K., Characteristics of cord blood collections: the COBLT Study cord blood bank experience, 2001.
M. S. Cairo, Wagner, E. L., Fraser, J., Cohen, G., van de Ven, C., Carter, S. L., Kernan, N. A., and Kurtzberg, J., Characterization of Banked Umbilical Cord Blood Hematopoietic Progenitor Cells (HPC) and Lymphocyte Subsets (LS) and Correlation with Ethnicity, Birth Weight, Gender and Type of Delivery: A COBLT Study Report, Transfusion, vol. 45, pp. 856-866, 2005.
J. Kurtzberg, Wagner, E. L., Gindy, L., Issitt, I., Carter, S. L., Kernan, N. A., Jensen, L., Cairo, M. S., and Fraser, J. K., The COBLT Study cord blood banking experience: donor recruitment, collection, processing, testing, and banking, 2001.
J. K. Fraser, Wagner, E. L., Carter, S. L., Kernan, N. A., Jensen, L., Rowan, E., and Kurtzberg, J., Cord blood donor pre-screening: Impact of exclusion criteria on minority recruitment, 2001.
E. L. Wagner, Brock, K. L., and Carter, S. L., The Cord Blood Transplantation (COBLT) Study: An internet data system for the COBLT Study Cord Blood Banks, 1999.
J. K. Fraser, Cairo, M. S., Wagner, E. L., McCurdy, P. R., Baxter-Lowe, L. A., Carter, S. L., Kernan, N. A., Lill, M. C., Slone, V., Wagner, J. E., Wallas, C. H., and Kurtzberg, J., Cord Blood Transplantation Study (COBLT): Cord Blood Bank Standard Operating Procedures, J Hematother, vol. 7, pp. 521-561, 1998.
J. Tolar, Deeg, H. J., Arai, S., Horwitz, M., Antin, J. H., McCarty, J. M., Adams, R. H., Ewell, M., Leifer, E. S., Gersten, I. D., Carter, S. L., Horowitz, M. M., Nakamura, R., Pulsipher, M. A., Difronzo, N. L., Confer, D. L., Eapen, M., and Anderlini, P., Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels, Biol Blood Marrow Transplant, vol. 18, pp. 1007-1011, 2012.
J. Wagner, Thompson, J., Carter, S. L., Jensen, L., and Kernan, N., Impact of Graft-Versus-Host Disease (GVHD) Prophylaxis on 3-Year Disease-Free Survival (DFS): Results of a Multi-Center, Randomized Phase II-III Trial Comparing T Cell Depletion/Cyclosporine (TCD) and Methotrexate/Cyclosporine (M/C) in 410 Recipients of U, 2002.
S. L. Carter, Jensen, L., Stablein, D., Flomenberg, N., Bishop, M., Martin, P., Kernan, N., Wagner, J., Thompson, J., Howe, C., and Geller, N., Implementation of a Large Randomized Prospective Clinical Trial in Unrelated Donor Bone Marrow (BM) Transplantation, 2002.
S. Pavletic, Carter, S. L., Weisdorf, D., Henslee-Downey, J., Papadopoulos, E., Gingrich, R., Casper, J., Kernan, N., and Yanovich, S., No Benefit of 1log T-cell Depletion on Chronic Graft vs Host Disease (cGVHD):Results of a Multi-Center Randomized Trial in 404 Recipients of Unrelated Donor Bone Marrow Transplantation (UBMT), 2003.
J. Bolanos-Meade, Logan, B. R., Alousi, A. M., Antin, J. H., Barowski, K., Carter, S. L., Goldstein, S. C., Hexner, E. O., Horowitz, M. M., Lee, S. J., Levine, J. E., MacMillan, M. L., Martin, P. J., Mendizabal, A. M., Nakamura, R., Pasquini, M. C., Weisdorf, D. J., Westervelt, P., and Ho, V. T., Phase 3 Clinical trial of Steroids/Mycophenolate Mofetil vs Steroids/Placebo as Therapy for Acute GVHD: BMT CTN 0802, Blood, vol. 124, pp. 3221-3227, 2014.
G. A. Yanik, Horowitz, M. M., Weisdorf, D. J., Logan, B. R., Ho, V. T., Soiffer, R. J., Carter, S. L., Wu, J., ,, Difronzo, N. L., Ferrara, J. L., Giralt, S., Madtes, D. K., Drexler, R., White, E. S., and Cooke, K. R., Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol, Biol Blood Marrow Transplant, vol. 20, no. 6, pp. 858-864, 2014.
J. Kurtzberg, Wagner, E. L., Fraser, J. K., Cairo, M. S., Jensen, L., Cohen, G., Carter, S. L., and Kernan, N. A., Results of the cord blood transplantation study (COBLT) unrelated donor banking program, Biol Blood Marrow Transplant, vol. 10, p. 21, 2004.
J. Kurtzberg, Cairo, M. S., Fraser, J. K., Baxter-Lowe, L., Cohen, G., Carter, S. L., and Kernan, N. A., Results of the Cord Blood Transplantation Study (COBLT) Unrelated Donor Banking Program, Transfusion, vol. 45, pp. 842-855, 2005.
J. K. Fraser, Wagner, E. L., Cairo, M. S., Stewart, A., Anthony, D., Carter, S. L., Kernan, N. A., Jensen, L., and Kurtzberg, J., Review of the COBLT Study Processing Procedures, 2000.
S. L. Carter, Search Process, 2000.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. H., Carter, S. L., Horowitz, M. M., and Antin, J. H., Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT, Blood, vol. 124, pp. 1372-1377, 2014.
K. Cornetta, Laughlin, M., Carter, S. L., Wall, D., Weinthal, J., Sievers, E., Wagner, J., Sweetman, R., McCarthy, P., Jensen, L., and Chao, N., Umbilical cord blood transplantation in adults: results of a prospective, multi-institutional, NHLBI sponsored trial, 2002.